Alida Reinoso
Miami, FLNPI 1831358233
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$3,371,220in research payments, 2019–2025
Across 721 payments — averaging $4675.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2.2M
- AbbVie$1.1M
- Supernus Pharmaceuticals, Inc.$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.